Hong Kong: Regulatory Requirements on the Use of Injectable and Infusible Products in Licensed Private Healthcare Facilities September 30, 2026
Taiwan: TFDA Introduces Electronic Review, Original Document Retention, and Electronically Approved Local Labeling September 14, 2026
Hong Kong: Updates on Guidance Notes for Listing Class II/III/IV General Medical Devices (GN-02) and Class B/C/D In Vitro Diagnostic Medical Devices (GN-06) August 7, 2026
Taiwan: TFDA Issues New Guidance for Antimicrobial Susceptibility Test (AST) Systems and Updates Guidance for C-Reactive Protein (CRP) Assays July 7, 2026
Taiwan: Public Consultation on Proposed Amendments to Medical Device Administrative Fees July 7, 2026
Taiwan: Public Consultation on Draft Amendment to Border Inspection Requirements for Imported Medical Devices June 3, 2026
Taiwan: Key Takeaways from TFDA Regulations & Management Communication Discussion Meeting April 22, 2026
Taiwan: TFDA Issues New Pre-clinical Testing Guidance for Bone Anchors, rTMS Systems, and Liquid Chemical Sterilants/High-Level Disinfectants March 25, 2026
